Laird Norton Wetherby Trust Company’s AbbVie ABBV Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.1M	Sell	71,949 -1,208	-2%	-$260K	0.35%	48
2026 Q1	$15.9M	Sell	73,157 -2,955	-4%	-$655K	0.35%	45
2025 Q4	$17.4M	Buy	+76,112	New	+$17.3M	0.36%	47
2024 Q4	–	Sell	-20,345	Closed	-$4.02M	–	81
2024 Q3	$4.02M	Sell	20,345 -7,096	-26%	-$1.32M	0.53%	29
2024 Q2	$4.71M	Hold	27,441	–	–	0.66%	23
2024 Q1	$5M	Sell	27,441 -9,384	-25%	-$1.62M	0.68%	24
2023 Q4	$5.71M	Buy	36,825 +33,215	+920%	+$4.84M	0.67%	23
2023 Q3	$538K	Buy	3,610 +24	+0.7%	+$3.52K	0.07%	62
2023 Q2	$483K	Hold	3,586	–	–	0.06%	66
2023 Q1	$571K	Hold	3,586	–	–	0.07%	61
2022 Q4	$579K	Buy	+3,586	New	+$550K	0.08%	54
2022 Q3	–	Sell	-3,819	Closed	-$584K	–	72
2022 Q2	$584K	Sell	3,819 -1,190	-24%	-$182K	0.07%	56
2022 Q1	$812K	Buy	5,009 +47	+0.9%	+$6.83K	0.07%	80
2021 Q4	$671K	Buy	4,962 +362	+8%	+$42.8K	0.06%	94
2021 Q3	$496K	Buy	4,600 +334	+8%	+$38.2K	0.05%	98
2021 Q2	$480K	Sell	4,266 -1,280	-23%	-$144K	0.05%	91
2021 Q1	$594K	Buy	5,546 +234	+4%	+$25K	0.07%	80
2020 Q4	$569K	Buy	+5,312	New	+$510K	0.06%	80

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Laird Norton Wetherby Trust Company's ABBV Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $260K and leaving 71,949 shares worth $18.1M. The position accounts for 0.35% of the portfolio, ranked #48.

Laird Norton Wetherby Trust Company first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Laird Norton Wetherby Trust Company held 71,949 shares of AbbVie worth $18.1M as of Q2 2026.
Laird Norton Wetherby Trust Company sold 1,208 AbbVie shares in Q2 2026, an estimated $260K.
AbbVie made up 0.35% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #48 holding.
Laird Norton Wetherby Trust Company first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.